PDT Partners LLC Takes $830,000 Position in Genpact Limited (NYSE:G)

PDT Partners LLC bought a new position in Genpact Limited (NYSE:GFree Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 21,165 shares of the business services provider’s stock, valued at approximately $830,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Jensen Investment Management Inc. boosted its holdings in shares of Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock valued at $7,449,000 after acquiring an additional 11,410 shares during the period. Vanguard Personalized Indexing Management LLC grew its position in Genpact by 53.1% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider’s stock worth $1,580,000 after purchasing an additional 17,034 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Genpact by 329.6% in the second quarter. Nisa Investment Advisors LLC now owns 10,525 shares of the business services provider’s stock valued at $339,000 after purchasing an additional 8,075 shares during the period. Access Investment Management LLC raised its holdings in shares of Genpact by 44.0% during the third quarter. Access Investment Management LLC now owns 212,875 shares of the business services provider’s stock valued at $8,347,000 after buying an additional 65,070 shares during the last quarter. Finally, Retirement Systems of Alabama boosted its position in shares of Genpact by 1.7% during the second quarter. Retirement Systems of Alabama now owns 449,845 shares of the business services provider’s stock worth $14,481,000 after buying an additional 7,645 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.80% of the stock is owned by corporate insiders.

Genpact Stock Performance

NYSE:G opened at $46.27 on Tuesday. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The company has a 50-day moving average of $41.31 and a 200-day moving average of $37.10. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $47.98. The firm has a market cap of $8.16 billion, a price-to-earnings ratio of 12.71, a price-to-earnings-growth ratio of 1.59 and a beta of 1.13.

Genpact Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 9th will be given a $0.1525 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 annualized dividend and a yield of 1.32%. Genpact’s dividend payout ratio (DPR) is 16.76%.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. BMO Capital Markets raised their target price on Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a research report on Monday, August 12th. Robert W. Baird lifted their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Jefferies Financial Group increased their target price on shares of Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 9th. JPMorgan Chase & Co. boosted their price target on shares of Genpact from $35.00 to $43.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Needham & Company LLC increased their price objective on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. Eight analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $42.33.

Check Out Our Latest Analysis on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.